Showing results (141-150 of 657) with videos related to
Sort By:
Pageof 66
Maturitas|December 25, 2013
The association between vasomotor symptoms and depression during perimenopause: a systematic reviewRoisin Worsley, Robin Bell, Jayashri Kulkarni, et al.Maturitas|August 5, 2014
Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancerPenelope J Robinson, Robin J Bell, Susan R DavisThe Journal of Clinical Endocrinology and Metabolism|April 19, 2022
Thyroid Hormone Abuse in Elite Sports: The Regulatory ChallengeMatti L Gild, Mark Stuart, Roderick J Clifton-Bligh, et al.European Journal of Endocrinology|July 9, 2013
Oral low-dose testosterone administration induces whole-body protein anabolism in postmenopausal women: a novel liver-targeted therapyVita Birzniece, Margot A Umpleby, Anne Poljak, et al.Journal of Neuroendocrinology|March 10, 2022
Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neuronsChris S Coyle, Melanie Prescott, David J Handelsman, et al.Breast Cancer Research : BCR|May 1, 2015
The role of androgens in experimental rodent mammary carcinogenesisJaesung Choi, Basil Psarommatis, Yan Ru Gao, et al.The Journal of Steroid Biochemistry and Molecular Biology|February 6, 2014
Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulationDavid J Handelsman, Amanda Idan, Janelle Grainger, et al.Endocrinology|January 16, 2014
In vivo actions of the Sertoli cell glucocorticoid receptorRasmani Hazra, Dannielle Upton, Mark Jimenez, et al.Journal of the Endocrine Society|November 6, 2020
Ultrasensitive Serum Estradiol Measurement by Liquid Chromatography-Mass Spectrometry in Postmenopausal Women and MiceDavid J Handelsman, Emma Gibson, Susan Davis, et al.JCEM Case Reports|April 24, 2025
Treatment With a Nonaromatizable Androgen for Transgender Man With a Hormone-sensitive Ovarian CancerSarina Lim, Ravind Pandher, Katrina Tang, et al.Pageof 66